Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.77 Billion CNY | 1.56% |
| 2022 | 2.73 Billion CNY | -18.27% |
| 2021 | 3.34 Billion CNY | -1.95% |
| 2020 | 3.41 Billion CNY | 1.55% |
| 2019 | 3.36 Billion CNY | -13.44% |
| 2018 | 3.88 Billion CNY | 1.98% |
| 2017 | 3.8 Billion CNY | 3.28% |
| 2016 | 3.68 Billion CNY | 11.64% |
| 2015 | 3.3 Billion CNY | 4.61% |
| 2014 | 3.15 Billion CNY | 13.36% |
| 2013 | 2.78 Billion CNY | 23.63% |
| 2012 | 2.25 Billion CNY | 18.35% |
| 2011 | 1.9 Billion CNY | 29.7% |
| 2010 | 1.46 Billion CNY | 12.24% |
| 2009 | 1.3 Billion CNY | 13.3% |
| 2008 | 1.15 Billion CNY | 14.67% |
| 2007 | 1 Billion CNY | 40.32% |
| 2006 | 717.18 Million CNY | -3.0% |
| 2005 | 739.37 Million CNY | 17.01% |
| 2004 | 631.9 Million CNY | 25.71% |
| 2003 | 502.66 Million CNY | 13.27% |
| 2002 | 443.78 Million CNY | 60.48% |
| 2001 | 276.53 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 588.51 Million CNY | 4.5% |
| 2024 Q3 | 545.64 Million CNY | -7.28% |
| 2024 Q1 | 563.14 Million CNY | -16.57% |
| 2023 Q1 | 683.79 Million CNY | 7.51% |
| 2023 Q3 | 657.13 Million CNY | -17.44% |
| 2023 Q2 | 795.9 Million CNY | 16.39% |
| 2023 FY | 2.77 Billion CNY | 1.56% |
| 2023 Q4 | 675.01 Million CNY | 2.72% |
| 2022 Q4 | 636.05 Million CNY | -2.62% |
| 2022 Q3 | 653.14 Million CNY | -13.85% |
| 2022 Q2 | 758.18 Million CNY | 10.22% |
| 2022 FY | 2.73 Billion CNY | -18.27% |
| 2022 Q1 | 687.87 Million CNY | -7.16% |
| 2021 Q2 | 862.28 Million CNY | 4.54% |
| 2021 Q1 | 824.8 Million CNY | -15.82% |
| 2021 FY | 3.34 Billion CNY | -1.95% |
| 2021 Q4 | 740.95 Million CNY | -19.34% |
| 2021 Q3 | 918.65 Million CNY | 6.54% |
| 2020 Q1 | 687.39 Million CNY | -19.36% |
| 2020 Q3 | 960.46 Million CNY | 22.28% |
| 2020 Q4 | 979.83 Million CNY | 2.02% |
| 2020 FY | 3.41 Billion CNY | 1.55% |
| 2020 Q2 | 785.48 Million CNY | 14.27% |
| 2019 Q4 | 852.48 Million CNY | -5.24% |
| 2019 Q1 | 824.62 Million CNY | -15.11% |
| 2019 Q3 | 899.66 Million CNY | 14.72% |
| 2019 FY | 3.36 Billion CNY | -13.44% |
| 2019 Q2 | 784.25 Million CNY | -4.9% |
| 2018 Q1 | 963.84 Million CNY | 3.29% |
| 2018 Q4 | 971.36 Million CNY | -4.66% |
| 2018 Q2 | 928.85 Million CNY | -3.63% |
| 2018 Q3 | 1.01 Billion CNY | 9.68% |
| 2018 FY | 3.88 Billion CNY | 1.98% |
| 2017 Q4 | 933.15 Million CNY | 1.14% |
| 2017 FY | 3.8 Billion CNY | 3.28% |
| 2017 Q3 | 922.61 Million CNY | -9.63% |
| 2017 Q2 | 1.02 Billion CNY | 9.67% |
| 2017 Q1 | 930.94 Million CNY | -7.1% |
| 2016 Q4 | 1 Billion CNY | 4.54% |
| 2016 FY | 3.68 Billion CNY | 11.64% |
| 2016 Q1 | 736.67 Million CNY | -11.71% |
| 2016 Q3 | 958.63 Million CNY | -3.11% |
| 2016 Q2 | 989.36 Million CNY | 34.3% |
| 2015 Q1 | 675.16 Million CNY | -36.52% |
| 2015 FY | 3.3 Billion CNY | 4.61% |
| 2015 Q4 | 834.35 Million CNY | -5.01% |
| 2015 Q3 | 878.37 Million CNY | -3.96% |
| 2015 Q2 | 914.62 Million CNY | 35.47% |
| 2014 Q4 | 1.06 Billion CNY | 26.27% |
| 2014 Q1 | 609.42 Million CNY | -40.65% |
| 2014 FY | 3.15 Billion CNY | 13.36% |
| 2014 Q2 | 641.85 Million CNY | 5.32% |
| 2014 Q3 | 842.28 Million CNY | 31.23% |
| 2013 FY | 2.78 Billion CNY | 23.63% |
| 2013 Q4 | 1.02 Billion CNY | 42.02% |
| 2013 Q3 | 722.98 Million CNY | 37.28% |
| 2013 Q1 | 508.43 Million CNY | -32.76% |
| 2013 Q2 | 526.66 Million CNY | 3.59% |
| 2012 Q3 | 549.76 Million CNY | 6.19% |
| 2012 FY | 2.25 Billion CNY | 18.35% |
| 2012 Q1 | 428.97 Million CNY | -27.65% |
| 2012 Q2 | 517.72 Million CNY | 20.69% |
| 2012 Q4 | 756.11 Million CNY | 37.53% |
| 2011 Q1 | 367.62 Million CNY | -19.03% |
| 2011 Q3 | 494.18 Million CNY | 10.15% |
| 2011 Q4 | 592.86 Million CNY | 19.97% |
| 2011 Q2 | 448.66 Million CNY | 22.04% |
| 2011 FY | 1.9 Billion CNY | 29.7% |
| 2010 Q4 | 454.01 Million CNY | 18.62% |
| 2010 Q1 | 282.98 Million CNY | -27.67% |
| 2010 FY | 1.46 Billion CNY | 12.24% |
| 2010 Q2 | 347.71 Million CNY | 22.88% |
| 2010 Q3 | 382.74 Million CNY | 10.07% |
| 2009 Q4 | 391.23 Million CNY | 18.87% |
| 2009 Q3 | 329.13 Million CNY | 4.82% |
| 2009 Q2 | 313.98 Million CNY | 14.99% |
| 2009 Q1 | 273.04 Million CNY | -18.27% |
| 2009 FY | 1.3 Billion CNY | 13.3% |
| 2008 Q4 | 334.06 Million CNY | 13.18% |
| 2008 FY | 1.15 Billion CNY | 14.67% |
| 2008 Q1 | 249.26 Million CNY | -27.57% |
| 2008 Q2 | 275.43 Million CNY | 10.5% |
| 2008 Q3 | 295.16 Million CNY | 7.16% |
| 2007 Q1 | 190.15 Million CNY | -25.07% |
| 2007 Q2 | 240.09 Million CNY | 26.26% |
| 2007 FY | 1 Billion CNY | 40.32% |
| 2007 Q4 | 344.16 Million CNY | 48.41% |
| 2007 Q3 | 231.9 Million CNY | -3.41% |
| 2006 Q2 | 153.47 Million CNY | 10.19% |
| 2006 Q1 | 139.28 Million CNY | -52.76% |
| 2006 Q4 | 253.78 Million CNY | 48.73% |
| 2006 Q3 | 170.63 Million CNY | 11.18% |
| 2006 FY | 717.18 Million CNY | -3.0% |
| 2005 Q4 | 294.86 Million CNY | 83.39% |
| 2005 FY | 739.37 Million CNY | 17.01% |
| 2005 Q1 | 121.21 Million CNY | -55.82% |
| 2005 Q2 | 162.51 Million CNY | 34.07% |
| 2005 Q3 | 160.78 Million CNY | -1.07% |
| 2004 Q1 | 115.73 Million CNY | 0.0% |
| 2004 Q3 | 114.25 Million CNY | -10.44% |
| 2004 Q2 | 127.57 Million CNY | 10.23% |
| 2004 FY | 631.9 Million CNY | 25.71% |
| 2004 Q4 | 274.34 Million CNY | 140.12% |
| 2003 FY | 502.66 Million CNY | 13.27% |
| 2002 FY | 443.78 Million CNY | 60.48% |
| 2001 FY | 276.53 Million CNY | 0.0% |